Our guiding principles - Pohl Boskamp

› At a glance › The family business › Facts & Figures › History › Our guiding principles › Social responsibility › [de] Kartoffelhalle Pohl-Boskamp

We take an active part in the international exchange of ideas with our partners looking for new development opportunities.

Our high level of pre-clinical work makes it possible to develop patient-friendly dosage forms quickly and efficiently. Our scientists are experienced specialists in the development of therapeutic concepts and in conducting clinical research. Our documentation team provides technical expertise to assure a smooth running process for product registration. Pohl-Boskamp has

invested significantly in each of these areas and now benefiting from the expertise of its staff.

We take an active part in the international exchange of ideas with our partners looking for new development opportunities.

As a manufacturer of pharmaceuticals and medical devices, we assume a special responsibility. To assure our patients are getting the best quality product possible, we have established a comprehensive Quality Assurance System.

Our documentation is meticulous and is only one element among many in our QA process. In the planning phase of new products every single function of the system and each individual production step is pre-defined, allowing us to validate our systems and processes on a regular basis. We have process controls at each step of production. As soon as a spray pump is mounted on a container, the spray function is tested with a special optical device to assure it is working properly. Right after a blister card is filled with capsules,

a camera checks whether the contents are accurate for every package.

Once the production process is complete, finished goods are submitted to the QA laboratory for final inspection before shipment.

› Home › Imprint

› Business

› At a glance

› The family business

› Our guiding principles

› Social responsibility

› Cardiovascular system

› Gastrointestinal tract

› Job & Career

› Contact

Baldurat^® – Active ingredient: dry extract of valerian root (3 - 6 : 1) [extraction agent: 70% ethanol (V/V)]. Indicated for the treatment of restlessness and disturbances in going sleep of nervous origin. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, D-25551 Hohenlockstedt, Germany (July 2001).

Nitrolingual akut^® Spray – Active ingredient: glyceryl trinitrate. Composition: 1 metered dose oromucusal spray contains 0.4 mg glyceryl trinitrate. Other ingredients: medium-chain triglycerides and partial glycerides, ethanol anhydrans, peppermint oil. Indications: prophylaxis and treatment of acute attacks of angina pectoris, acute myocardial infarction, acute left-ventricular heart failure, catheter-induced coronary spasms. Contraindications: hypersensitivity to any of the ingredients or other nitrate compounds, acute circulatory failure, cardiogenic shock, marked hypotension (syst BP < 90 mmHg), intake of phosphodiesterase inhibitors for the treatment of erectile dysfunction or pulmonary arterial hypertension. Caution in cases of hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, low filling pressures (e.g. in cases of acute MI; avoid syst BP < 90 mmHg), aortic and/or mitral stenosis, orthostatic circulatory disorders, increased intracranial pressure. During pregnancy and breast-feeding, only after careful consideration whether the benefits outweigh the risks. Side effects: headache very frequent at the start of treatment, frequent hypotension with reflex tachycardia, drowsiness, dizziness and weakness. Occasional nausea, vomiting, flush, allergic skin reactions, marked decreases in blood pressure with exacerbation of angina pectoris symptoms, bradycardia with fainting. Very rare, exfoliative dermatitis. Development of tolerance and cross tolerance possible, avoid continuous high dosing. Hypoxaemia and ischaemia may occur in CHD. The ability to drive vehicles or operate machines may be impaired, especially in combination with alcohol consumption. PO. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (1).

GeloMyrtol^® forte – Active ingredient: distillate of a mixture of rectified eucalyptus oil, rectified sweet orange oil, rectified myrtle oil and rectified lemon oil (66:32:1:1) (Myrtol^® standardized). Indicated for acute and chronic bronchitis and inflammation of the maxillary sinuses (sinusitis). For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/6).

Laxopol^® 1.0 g – Active ingredient: refined castor oil. For the short-term treatment of constipation. Medical advice should sought for constipation that lasts for longer than 1 week. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (6).

GeloBronchial^®-Saft – Active ingredient: liquid extract of thyme. Indications: common cold like disorders of the airways with catarrh, alleviation of symptoms of bronchitis. Warning: Ingredients include invert sugar syrup and 6.3 Vol.-% alcohol. Diabetics: sugar content of 0.75 BEU per 15 mL syrup. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/11).

GeloDurat^®-Salbe – Active ingredient: eucalyptus oil and levomenthol. For external use to alleviate the symptoms of respiratory tract infections (common cold, hoarseness and uncomplicated bronchial catarrh). For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/5).

Nitrolingual^® infus. – Active ingredient: glycerol trinitrate. Composition: 1 ml infusion solution contains 1 mg glycerol trinitrate. Other ingredients: glucose monohydrate (Ph.Eur.), 10% hydrochloric acid solution (for pH adjustment), water for injections. Indications: severe angina pectoris, acute myocardial infarction, acute left-ventricular heart failure, hypertensive crisis with acute heart failure, controlled hypotension. Contraindications: hypersensitivity to any of the ingredients or other nitrate compounds, acute circulatory failure, cardiogenic shock, toxic pulmonary oedema, marked hypotension (syst BP < 90 mmHg), disorders with increased intracranial pressure, intake of phosphodiesterase inhibitors for the treatment of erectile dysfunction or pulmonary arterial hypertension. Caution in cases of hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, low filling pressures (e.g. in cases of acute MI; avoid syst BP < 90 mmHg), aortic and/or mitral valve stenosis, tendency to orthostatic circulatory disorders, severe liver or kidney disturbances. During pregnancy and breast-feeding, only if prescribed by a physician. Side effects: headache very frequent at the start of treatment; hypotension with reflex tachycardia may occur. Occasional nausea, vomiting, flush, allergic skin reactions, marked decreases in blood pressure with exacerbation of angina pectoris symptoms, bradycardia with fainting and synopses. Very rare, exfoliative dermatitis. Development of tolerance and cross tolerance possible, avoid continuous high dosing. Hypoxaemia and ischaemia may occur in CHD. The ability to drive vehicles or operate machines may be impaired, especially in combination with alcohol consumption. PO. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (July 2008).

GeloVital^® Lebertrankapseln – 0.5 g/1.0 g – Active ingredient: Codliveroil for general strengthening and invigoration. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/5/2).

GeloNasal^®- 0.05%/-Spray 0.10% – Active ingredient: xylometazoline hydrochloride. Indications: for local application in the nose. Contains the alpha-sympathomimetic xylometazoline. This substance narrows the blood vessels thereby reducing swelling of the mucous membrane. GeloNasal^®-Tropfen 0.05%: for children between 2 and 6 years; GeloNasal^®-Spray 0.10%: for schoolchildren older than 6 years and adults. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/13/13).

Gelo^®-Bronchialtee 400 – Active ingredients: dry extract of thyme (6.0 – 10.0:1) [70% (V/V) ethanol] and ivy leaves (4.0 – 7.5:1) [30% (V/V) ethanol]. Indications: common cold and upper respiratory tract infections (catarrh), alleviation of symptoms of bronchitis. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt (01/01).